SYNBALANCE SRL PROBIOTICS
Synbalance SRL has been created to become the leader in the biotech industry. starting from a strong commitment to people health through the modulation of gut microbiota. We trust Probiotics, their derivatives and those microbiome-related technologies as cutting edge solutions for a new where health comes through prevention of chronic disease and ageing. The expertise on ingredient and finished product development is at the service of innovation and customisation.
An Italian company part of ROELMI HPC srl focused on the design, development and manufacturing of top quality probiotic bacteria.
Offering a wide selection of proprietary strains belonging to Lacobacilli, Bifidobacteria and other species developed through cutting-edge bio-fermentation technology.
SynBalance® SmilinGut, SynBalance® HappyBelly, SynBalance® DRstop, SynBalance® DRstop AB, SynBalance® DRstop Travel, SynBalance® EnzyME, SynBalance® Wellderly
Genetic and external factors could affect a balanced microbiota moving from a eubiotic to a dysbiotic status (an alteration in microbiota community structure and/or function), capable of causing-driving a detrimental distorted gut homeostasis.
Gut-Brain Axis Probiotics
With “Gut-Brain-Axis” we refer to a bidirectional cross-talk between intestine and central nervous system. This connection is not only useful to guarantee the correct digestive pathway but thanks to gut microbiota it also possible to positively modulate brain functions. Stress and related sleep disorders are becoming the damage of our time, triggering a vicious circle that could affect our mood sphere. Indeed, this situation led to the development of discomforts like: migraine, fatigue, weakness, lack of energy and vitality, insomnia.
Gut-Skin Axis Probiotics
SynBalance® ProBeautyShield – AD, SynBalance® ProBeautyShield – Acne
The correlation between skin and intestine – the gut–skin axis – it is now clearer: gut unbalances can affect skin by inducing systemic inflammation, thus triggering dermatological diseases like atopic dermatitis (AD) or acne with serious complication in the quality of everyday life.
SynBalance® AllergAway, SynBalance®
DefensePlus, SynBalance® Wellderly,
SynBalance® ProBeautyShield – AD
Inflammation is the body’s defence mechanism against cellular aggression. Due to trauma, physical/chemical elements (UVR), tissue death, foreign bodies, immune reactions is often associated with oxidative stress. Moreover, SynBalance® strains produce group B vitamins as natural fermentation metabolites: each of which is either a cofactor or a precursor involved in key metabolic processes
Metabolic & Weight Probiotics
SynBalance® MetSyn, SynBalance® CholDown, SynBalance® KcALT
Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity. CMS is now recognized as a disease entity by the World Health Organization. Overweight and obesity are major risk factors for a number of chronic diseases, including diabetes, cardiovascular diseases and cancer.
Sport Nutrition Probiotics
Sports nutrition plays a key role in optimizing the beneficial effects of physical activity with the aim to improve mental and physical health. Together with exercise and a balanced diet, probiotics can support athlete’s performance representing an innovative solution in order to promote intestinal health, immune defenses and overall well-being in sportive people.
SynBalance® Femme, SynBalance®
GynElle, SynBalance® EnjoyMum, SynBalance® Lady
Women are more prone to suffer from bacterial and yeast infections. Bacterial vaginosis (BV) and vulvo-vaginal candidacies (VVC) are infections widely spread among women in childbearing age. These infections are associated with altered or disturbed vaginal microbiota, in a condition defined as vaginal dysbiosis. Restoration of the lactobacilli ecosystem seems a promising strategy for the treatment of these conditions. Globally, BV is the most common cause of vaginal discomforts among women ages 15-44 and more than 20% of the female population is affected.